Bacteriophage Therapy Market Size, Share, Outlook, and Opportunity Analysis, 2020– 2027

1. BACTERIOPHAGES THERAPY MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Bacteriophage Therapy Market- Overview Global Bacteriophage Therapy Market, by Targeted Bacteria (Escherichia coli, Staphylococcus, Streptococcus, Pseudomonas, Salmonella, and Others), by Route of Administration (Oral, Topical, and Parenteral), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Increasing prevalence and awareness of antimicrobial-resistant infection is driving adoption of phage therapy for treatment of such infections which is expected to drive the market growth. For instance, according to World Health Organization, in 2016, around 490,000 people developed multi-drug resistant TB globally. This drug resistance has also impacted the management and treatment of other infections such as malaria and HIV. As a result there is increasing inclination among the populace towards non-traditional therapeutics for treating such infections. Manufacturers are focusing on the development of an effective phage therapy to control such drug resistant infection. Moreover, increasing approvals from drug regulatory authorities for development phage therapy candidates are contributing to growth of the market. For instance, in February 2019, the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application to conduct the first U.S. clinical trial of an intravenously administered bacteriophage-based therapy. Browse Research Reports: https://www.coherentmarketinsights.com/market- insight/bacteriophages-therapy-market-2752 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Browse 146 Pages and in-depth TOC on ‘Bacteriophage Therapy Market’- Global Bacteriophage Therapy Market, by Targeted Bacteria (Escherichia coli, Staphylococcus, Streptococcus, Pseudomonas, Salmonella and Others), by Route of Administration (Oral, Topical and Parenteral), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), North America is expected to hold a dominant position in the bacteriophage therapy market over the forecast period, owing to rising prevalence of antibiotic resistant infections in the region. For instance, according to the Centers for Disease Control and Prevention, in 2018, around 2 million people had antibiotic-resistant infection and around 23,000 people died from antibiotic resistant infections each year in the U.S. Europe is expected to witness growth in the bacteriophage therapy market over the forecast period due to expansion of manufacturing facility for producing bacteriophage therapy, and rising research and development activities by market players in the region. For instance, in June 2015, AmpliPhi BioSciences Corporation, developer of bacteriophage-based antibacterial therapies, received the Good Manufacturing Practices (cGMP) certification from JAZMP, agency of the Republic of Slovenia for Medicinal Products and Medical Devices, for the manufacturing of bacteriophages (Staphylococcus aureus and Pseudomonas aeruginosa) at its facility in Slovenia. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/2752 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Key Takeaways of the Bacteriophage Therapy Market: The global bacteriophage therapy market is expected to grow over the forecast period owing to inorganic growth strategies such as partnerships, collaborations, acquisitions among market players. For instance, in March 2018, AmpliPhi Biosciences Corporation (Armata Pharamceutical Inc.) collaborated with the U.S. Department of Veterans Affairs for expanding access for its investigational bacteriophage candidates, AB-SA01 and AB-PA01, within VA Palo Alto Health Care System. Key players operating in the global bacteriophage therapy market are Armata Pharmaceuticals, Inc., Eliava Biopreparations Ltd., Pherecydes Pharma, Intralytix, Inc., Phagelux Inc., Nextbiotics, InnoPhage, Ltd, Locus Biosciences, Inc., TechnoPhage, Eligo Bioscience SA, Phagomed Biopharma GmbH., PhagePro, Inc., Adaptive Phage Therapeutics, Inc., EnBiotix, Inc., Intodeworld, Inc., BiomX Ltd., Phi Therapeutics, Fixed-phage Ltd., Micreos BV, and ContraFect Corporation. The application for the clinical study has been submitted by physician-scientists at the University Of California San Diego School Of Medicine. Following the U.S. FDA approval, the company plans to initiate phase I/II clinical trial study to test AB-SA01, an experimental bacteriophage combination for treatment of participants with ventricular assist devices (VADs) infected by resistant Staphylococcus aureus (S. aureus). Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2752 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved